Sygnature Discovery is a world-leading integrated drug discovery and non-clinical solutions provider, offering expertise across a broad range of therapeutic areas and biological target classes.

https://www.sygnaturediscovery.com/

We have >1000 employees located in the UK and North America with deep expertise in computational, synthetic, medicinal and process chemistry, in vitro and in vivo pharmacology, DMPK, Solid Form and Formulation.

Since 2011 we have supported the discovery of 41+ compounds which have proceeded into preclinical tox, Phase I-III trials. Our inventors are named on 170+ patents, delivering significant value to our clients.